New Ursane–Ent-Kaurane Dimer Skeleton Isolation via Stepwise Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a lack of comprehensive understanding and utilization of the chemical ingredients of the I. trichantha plant, particularly in the development of compounds with potential anti-tumor and antibacterial activities.
Innovation Solution
The extraction and separation of two compounds, Bisicacinol B (1) and Bisicacinol C (2), with a new ursane triterpenoid-ent-kaurane diterpenoid dimer skeleton from the tuber of I. trichantha, using a multi-step chromatographic process involving ethanol extraction, solvent fractionation, and various chromatographic techniques.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multi-step extraction and separation processes are used to obtain pure compounds, then compound purity and anti-tumor activity are improved, but process complexity and time consumption increase
Solution Approach 1:
The extraction and separation process is divided into multiple sequential steps: ethanol extraction, solvent fractionation (petroleum ether, dichloromethane, ethyl acetate, n-butanol), macroporous resin chromatography, silica gel chromatography, and MCI chromatography. Each step separates compounds based on different properties, achieving high purity isolation of Bisicacinol B and C through systematic segmentation of the separation process
Solution Approach 2:
Multiple intermediary substances and media are used throughout the process: ethanol as extraction solvent, various organic solvents for fractionation, macroporous resin and silica gel as chromatographic media, and MCI resin for final separation. These intermediaries facilitate stepwise purification by interacting differently with compounds based on their chemical properties
2Ease of manufacture
If traditional extraction methods are used to obtain chemical ingredients, then extraction simplicity is maintained, but anti-tumor activity and clinical application value are insufficient
Solution Approach 1:
The extraction process utilizes changes in solvent polarity and concentration parameters: starting with ethanol aqueous solution (polar), progressing through various organic solvents with different polarities, and using chromatographic media with varying retention characteristics. These parameter changes enable selective extraction and separation of compounds with specific anti-tumor activities from the complex plant matrix
3Loss of information
If comprehensive chemical ingredient analysis is performed, then understanding of plant active ingredients is improved, but research time and resource consumption increase
Solution Approach 1:
The study performs preliminary extraction and separation of active ingredients before comprehensive analysis. By pre-isolating compounds like Bisicacinol B and C through systematic extraction, the research establishes a foundation for further detailed analysis, reducing the time needed for complete chemical characterization while capturing key active ingredients
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The compounds demonstrate significant anti-tumor activity against pancreatic, colon, and lung cancers, as well as antibacterial activity against Helicobacter pylori and Candida albicans, providing a scientific basis for clinical applications.
Implementation Method 1
adding ethanol aqueous solution, refluxing the mixture for extraction of medicinal material
Implementation Method 2
subjecting the dichloromethane fraction obtained in the step (2) to AB-8 macroporous resin atmospheric column chromatography, and eluting the product with ethanol aqueous solution
Data Source
AI summary
Disclosed are two compounds with a new skeleton of ursane triterpenoid—ent-kaurane diterpenoid dimer and a preparation method thereof. According to the invention, chemical ingredients of a tuber of a West African plant I. trichantha are deeply studied, and separated to obtain two compounds Bisicacinol B (1) and Bisicacinol C (2), and the compounds are both a natural hybrid dimer formed by a DielsAlder addition or Michael addition reaction between a ursane triterpenoid with a unique spiro structure and an ent-kaurane diterpenoid. Pharmaceutical experiments show that the Bisicacinol B (1) and Bisicacinol C (2) prepared by the invention have a significant anti-tumor activity (on a pancreatic cancer, a colon cancer, a lung cancer, or a liver cancer), and can also be combined with an amphotericin B to exert a coordinated and synergistic anti-Candida albicans activity.